title: A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe.
authors: Blizard Institute, Barts and The London School of Medicine and Dentistry, Neuroscience and Trauma, 4 Newark Street, Clapham, London E1 2AT, United Kingdom. Electronic address: g.giovannoni@qmul.ac.uk.
authors: Gavin
authors: G
authors: Giovannoni
authors: Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
authors: Brigit
authors: B
authors: de Jong
authors: Department of Neurology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
authors: Tobias
authors: T
authors: Derfuss
authors: Unidad de EM. CSUR, Hospital Universitario Macarena, Dr Fedriani 3, 41009 Sevilla, Spain.
authors: Guillermo
authors: G
authors: Izquierdo
authors: Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, United Kingdom.
authors: Gordon
authors: G
authors: Mazibrada
authors: Department of Neurology, Cambridge University Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, United Kingdom.
authors: Paul
authors: P
authors: Molyneux
authors: Department of Neurology, Imperial Healthcare NHS Trust, Charing Cross Hospital, United Kingdom.
authors: Richard
authors: R
authors: Nicholas
authors: Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, United Kingdom.
authors: James
authors: J
authors: Overell
authors: Center of Clinical Neuroscience, Department of Neurology, Neurological University Clinic Dresden, University Clinic Carl Gustav Carus Dresden, University of Technology Dresden, Fetscherstr, 74, 01307 Dresden, Germany.
authors: Tjalf
authors: T
authors: Ziemssen
authors: Department of Laboratory Medicine, Stem Cell Center, Lund University, Sweden; Department of Hematology, Skåne University Hospital, Sweden.
authors: Gunnar
authors: G
authors: Juliusson
mesh_terms: D005060:Europe; D000068876:Fingolimod Hydrochloride / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008231:Lymphopenia / Q000139:chemically induced*; D009103:Multiple Sclerosis / Q000188:drug therapy
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride